JPRN-jRCT2051200119已完成1 期
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)
Shimizu Tomohito0 个研究点目标入组 20 人开始时间: 2021年1月22日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 44age old（—）
- 性别
- Male
入选标准
- •The subjects will be individuals who meet all of the following criteria.
- •[1] Healthy men
- •[2] Individuals >=20 to <45 years of age at the time of informed consent
- •[3] Individuals who fully understand the details of the study and who are capable of providing written informed consent
排除标准
- •Individuals meeting any of the following criteria will be excluded from the study.
- •[1] Past history of disease of kidney, liver, heart, brain, or other conditions considered unsuitable for this study
- •[2] Past history of disease or surgery that could affect absorption of the investigational product or designated concomitant drug
- •[3] Other protocol defined exclusion criteria could apply
研究者
相似试验
已完成
1 期
Clinical Pharmacology Study of AK1830 (Drug-Drug Interaction Study in Healthy Men)JPRN-jRCT2051200123Shimizu Tomohito40
未知
3 期
A clinical pharmacological study of SK-0403Type 2 diabetes mellitusJPRN-jRCT2080221260SANWA KAGAKU KENKYUSHO CO.,LTD.20
未知
1 期
A phase I clinical pharmacology study of TAK-233 in healthy subjectsHealthy adult female subjectsJPRN-jRCT2080222396TAKEDA PHARMACEUTICAL COMPANY LTD.24
未知
3 期
A General Clinical Pharmacological Study of TRK-820 Soft Capsules - Refractory Pruritus in Patients on Peritoneal DialysisJPRN-jRCT2080222514Toray Industries,Inc.
未知
1 期
Clinical pharmacology study of K-877DyslipidemiaJPRN-jRCT2080222359Kowa Co., Ltd.32